AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.90
-2.40 (-3.79%)
Sep 8, 2026, 12:50 PM CST

AnnJi Pharmaceutical Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
456.27346.47629.04597.86267.9391.41
Short-Term Investments
4276274--
Trading Asset Securities
--0.975.51--
Cash & Short-Term Investments
460.27348.47706.01877.37267.9391.41
Cash Growth
-8.96%-50.64%-19.53%227.50%-31.55%-
Accounts Receivable
0.080.140.15-0.09-
Other Receivables
0.550.430.673.9212.4910.51
Receivables
0.630.560.823.9212.5810.51
Inventory
20.5418.1127.42-4.895.31
Prepaid Expenses
10.022.649.5637.5420.144.95
Total Current Assets
491.45369.78743.8918.82305.51412.18
Property, Plant & Equipment
63.1768.176.482.086.7311.18
Long-Term Investments
83.2683.2679.269.7859.439.6
Other Intangible Assets
50.0766.94100.6134.57168.75202.74
Other Long-Term Assets
2.032.0322.740.840.84
Total Assets
689.98590.111,0021,208541.23666.54

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
--0.12---
Accrued Expenses
54.654.5348.3948.092711.7
Current Portion of Leases
6.946.265.985.8-2.79
Current Income Taxes Payable
39.538.9840.6638.08--
Current Unearned Revenue
--192.73126.091.6-
Other Current Liabilities
36.3732.679.552.121.76
Total Current Liabilities
137.41102.77290.54227.630.7216.25
Long-Term Leases
39.3643.149.3655.34--
Other Long-Term Liabilities
94.22124.41---0.16
Total Liabilities
271270.29339.9282.9430.7216.41

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,009940.64936.92908.61658.76623.76
Additional Paid-In Capital
1,207969.15961.07909.67426.15384.49
Retained Earnings
-1,865-1,658-1,300-946.02-616.8-380.15
Comprehensive Income & Other
68.1867.964.1152.7842.422.03
Shareholders' Equity
418.98319.82662.1925.04510.51650.13
Total Liabilities & Equity
689.98590.111,0021,208541.23666.54

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
46.349.3655.3461.13-2.79
Net Cash (Debt)
413.96299.11650.67816.24267.9388.62
Net Cash Growth
-8.65%-54.03%-20.28%204.68%-31.06%-
Net Cash Per Share
4.323.197.0010.554.088.60
Filing Date Shares Outstanding
100.9494.0693.6990.8665.8845.2
Total Common Shares Outstanding
100.9494.0693.6990.8665.8845.2
Working Capital
354.04267453.26691.22274.79395.93
Book Value Per Share
4.153.407.0710.187.7514.38
Tangible Book Value
368.92252.88561.5790.47341.76447.39
Tangible Book Value Per Share
3.652.695.998.705.199.90
Machinery
36.5536.0733.7735.0536.3636.24
Construction In Progress
---8.03--
Leasehold Improvements
17.0117.0116.947.584.284.28